Economic evaluation of biosimilars for reimbursement purposes – what, when, how? by Evelien Moorkens, Hannah Broux, Isabelle Huys, Arnold G. Vulto, Steven Simoens

Subjects: Get full text

Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysis by Teresa Barcina Lacosta, Arnold G. Vulto, Arnold G. Vulto, Isabelle Huys, Steven Simoens

Subjects: Get full text

An exploration of biosimilar TNF-alpha inhibitors uptake determinants in hospital environments in Italy, Portugal, and Spain by Teresa Barcina Lacosta, Arnold G. Vulto, Arnold G. Vulto, Isabelle Huys, Steven Simoens

Subjects: Get full text

The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape by Evelien Moorkens, Nicolas Meuwissen, Isabelle Huys, Paul Declerck, Arnold G. Vulto, Steven Simoens

Subjects: “…Off-patent biological medicine…”
Get full text